MedTrace Logo

Central Pain Syndrome in Survivors of Head and Neck Cancer

NCT04128267 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-09-19

Study results available
· View outcomes & findings →

Summary

This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.

Conditions

Interventions

DEVICE

IPC-1000

Delivers pressure to thumbnail for five seconds at a time

DEVICE

Magnetic resonance imaging

Scan of brain using Magnetic resonance imaging

OTHER

Correlative Studies

Administration of questionnaires via computer

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Dianne Lou, MD, PhD · Vanderbilt Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2022-07-21
Completion
2022-07-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128267 on ClinicalTrials.gov